AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27126398 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine, fluoxetine
Number of subjects: 0
Study 27126398 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine, stress inoculation training (SIT)
Number of subjects: 0
Study 27126398 — intervention group
Group type: COMPARATOR
Intervention: Bupropion, citalopram, divalproex, mirtazapine, tiagabine, topiramate
Number of subjects: 0
Study 27126398 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole, divalproex, guanfacine, olanzapine (combined with an antidepressant)
Number of subjects: 0
Study 24816151 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard vest plus retroreflective strips positioned on the extremities in a configuration that conveyed biological motion (biomotion)
Number of subjects: 24
Study 24816151 — intervention group
Group type: COMPARATOR
Intervention: Standard road worker vest
Number of subjects: 24
Study 23093479 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac/hyoscine butylbromide (10 mg/20 mg)
Number of subjects: 160
Study 23093479 — intervention group
Group type: COMPARATOR
Intervention: Hyoscine butylbromide (20 mg)
Number of subjects: 160
Study 20485915 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-oily capsules containing vitamin D3 66,000 UI plus vitamin A 13,200 UI
Number of subjects: 18
Study 20485915 — intervention group
Group type: COMPARATOR
Intervention: Oily drops containing vitamin D3 66,000 UI plus vitamin A 13,200 UI
Number of subjects: 18
Study 18589718 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg two times a day)
Number of subjects: 40
Study 15895289 — intervention group
Group type: EXPERIMENTAL
Intervention: LED irradiation (2 min at a continuous power output of 160 mW, radiant exposure of 1.07 J/cm(2))
Number of subjects: 64
Study 15895289 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation (placebo)
Number of subjects: 64
Study 11929403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 10 mg
Number of subjects: 36
Study 11929403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 36
Study 11929403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 36
Study 10555738 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid Gas Permeable (RGP) lenses
Number of subjects: 29
Study 10555738 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 29
Study 7674186 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc phosphate cement
Number of subjects: 0
Study 7674186 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement
Number of subjects: 0
Study 7674186 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement with a dentinal bonding agent
Number of subjects: 0
Study 7674186 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 2174321 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate meal
Number of subjects: 9
Study 2174321 — intervention group
Group type: COMPARATOR
Intervention: High fat meal
Number of subjects: 9
Study 31736022 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal levobupivacaine 20 mL
Number of subjects: 3
Study 31736022 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional levobupivacaine 20 mL
Number of subjects: 3
Study 31736022 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal + Incisional levobupivacaine 20 mL each
Number of subjects: 3
Study 30620869 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Zinc plus Arginine dentifrice (0.96% zinc oxide, 1.5% Arginine, 1450 ppm fluoride)
Number of subjects: 100
Study 30620869 — intervention group
Group type: COMPARATOR
Intervention: Regular fluoride dentifrice (1450 ppm fluoride)
Number of subjects: 100
Study 26026183 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive videophone communication
Number of subjects: 68
Study 26026183 — intervention group
Group type: COMPARATOR
Intervention: Individualized printed communication
Number of subjects: 68
Study 26026183 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (printed and videophone)
Number of subjects: 68
Study 24447269 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 16
Study 24447269 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 16
Study 22767584 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide 100 mg/m(2) for 14 consecutive days in six 28-day cycles (CMF)
Number of subjects: 317
Study 22767584 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (CMF or AC, provider/patient choice)
Number of subjects: 317
Study 19925626 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 1000
Study 19925626 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous sumatriptan (6 mg) with MAOI-A
Number of subjects: 1000
Study 18666395 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinonide cream 0.1%
Number of subjects: 20
Study 18666395 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate cream 0.05%
Number of subjects: 20
Study 16424840 — intervention group
Group type: EXPERIMENTAL
Intervention: Less incision retroperitoneal approach (group-L), incision length 11.9±1.8 cm
Number of subjects: 27
Study 16424840 — intervention group
Group type: COMPARATOR
Intervention: Conventional incision (group-C), incision length 17.8±1.9 cm
Number of subjects: 27
Study 12840180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary EPA+DHA (0.8 or 1.7g/d)
Number of subjects: 150
Study 12840180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary ALA (4.5 or 9.5g/d)
Number of subjects: 150
Study 12840180 — intervention group
Group type: COMPARATOR
Intervention: Control (linoleic acid; LA)
Number of subjects: 150
Study 11789185 — intervention group
Group type: EXPERIMENTAL
Intervention: Danzhi Xiaoyao powder (DZXY) with conventional therapy
Number of subjects: 51
Study 11789185 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 51
Study 8689878 — intervention group
Group type: EXPERIMENTAL
Intervention: Advantage 24
Number of subjects: 33
Study 8689878 — intervention group
Group type: COMPARATOR
Intervention: Conceptrol
Number of subjects: 33
Study 8689878 — intervention group
Group type: COMPARATOR
Intervention: Sponge
Number of subjects: 33
Study 1739355 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem plus amikacin
Number of subjects: 750
Study 1739355 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 750
Study 1739355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus amikacin
Number of subjects: 750
Study 1739355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 750
Study 6391333 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% topical flurbiprofen
Number of subjects: 34
Study 6391333 — intervention group
Group type: COMPARATOR
Intervention: Routine preoperative dilating drops (Control)
Number of subjects: 34
Study 31771601 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP-DC (autologous dendritic cells pulsed with personalized peptides)
Number of subjects: 0
Study 31771601 — intervention group
Group type: COMPARATOR
Intervention: OC-DC (autologous dendritic cells loaded with oxidized tumor lysate)
Number of subjects: 0
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac Troponin-T (hs-cTnT)
Number of subjects: 119
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine kinase MB iso-enzyme (CKMB)
Number of subjects: 119
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro B-type Natriuretic Peptide (NT-proBNP)
Number of subjects: 119
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak hs-cTnT
Number of subjects: 119
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: Early EF
Number of subjects: 119
Study 30049462 — intervention group
Group type: EXPERIMENTAL
Intervention: IS and EF at 4 ± 2 days
Number of subjects: 119
Study 27366013 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 300 mg once daily for 12 weeks
Number of subjects: 39
Study 27366013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 24184169 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 10939
Study 24184169 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 10939
Study 22267243 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training for 4 weeks
Number of subjects: 120
Study 22267243 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 120
Study 19328328 — intervention group
Group type: EXPERIMENTAL
Intervention: FNGS 2.0
Number of subjects: 21
Study 19328328 — intervention group
Group type: COMPARATOR
Intervention: Original FNGS
Number of subjects: 21
Study 18156665 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid/creatine/energy supplement (S)
Number of subjects: 8
Study 18156665 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin placebo (P)
Number of subjects: 8
Study 15889114 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion
Number of subjects: 46
Study 15889114 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (8 and 40 mU/m2/min)
Number of subjects: 46
Study 15889114 — intervention group
Group type: COMPARATOR
Intervention: Control group (AGA)
Number of subjects: 46
Study 12486865 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate (400 micrograms day-1)
Number of subjects: 20
Study 12486865 — intervention group
Group type: COMPARATOR
Intervention: Folic acid (400 micrograms day-1)
Number of subjects: 20
Study 9657560 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 0
Study 9657560 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 50 mg
Number of subjects: 0
Study 9657560 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 2 mg
Number of subjects: 0
Study 9657560 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (pooled 10 and 50 mg)
Number of subjects: 0
Study 9657560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7667645 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX)
Number of subjects: 0
Study 7667645 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 0
Study 2696322 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive clothing (shirts and trousers impervious to bacteria)
Number of subjects: 20
Study 2696322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet radiation
Number of subjects: 20
Study 1155062 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon 300 mug/kg i.m. (Group B)
Number of subjects: 30
Study 1155062 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon 300 mug/kg i.v. (Group C)
Number of subjects: 30
Study 1155062 — intervention group
Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 30
Study 29439358 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed visual training
Number of subjects: 35
Study 29439358 — intervention group
Group type: EXPERIMENTAL
Intervention: Undirected visual training
Number of subjects: 35
Study 29439358 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual training (both directed and undirected)
Number of subjects: 35
Study 28108927 — intervention group
Group type: EXPERIMENTAL
Intervention: smalltalk group-only (toddler trial)
Number of subjects: 2186
Study 28108927 — intervention group
Group type: EXPERIMENTAL
Intervention: smalltalk plus (toddler trial)
Number of subjects: 2186
Study 28108927 — intervention group
Group type: EXPERIMENTAL
Intervention: smalltalk plus (infant trial)
Number of subjects: 2186
Study 28108927 — intervention group
Group type: COMPARATOR
Intervention: standard program (control for toddler trial)
Number of subjects: 2186
Study 28108927 — intervention group
Group type: COMPARATOR
Intervention: standard/usual practice controls (infant trial)
Number of subjects: 2186
Study 26022961 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham CPAP
Number of subjects: 59
Study 26022961 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 59
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Item banks for alcohol use
Number of subjects: 1407
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Item banks for negative consequences of alcohol use
Number of subjects: 1407
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Item banks for positive consequences of alcohol use
Number of subjects: 1407
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Item banks for negative expectancies regarding drinking
Number of subjects: 1407
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Item banks for positive expectancies regarding drinking
Number of subjects: 1407
Study 23206377 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven-item static short forms from each item bank
Number of subjects: 1407
Study 21621722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation targeted to C5/C6 segment
Number of subjects: 37
Study 19171507 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-guided occult lesion localization
Number of subjects: 0
Study 19171507 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided localization
Number of subjects: 0
Study 16318177 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-optic device mounted on a slit lamp to assess the degree of polarization of a light beam.
Number of subjects: 0
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 200 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 400 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 200 mg and 400 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg and 400 mg
Number of subjects: 226
Study 12242597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study 10355678 — intervention group
Group type: EXPERIMENTAL
Intervention: Drawings of tools (man-made objects)
Number of subjects: 0
Study 10355678 — intervention group
Group type: EXPERIMENTAL
Intervention: Drawings of animals and fruit (natural objects)
Number of subjects: 0
Study 10355678 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing and matching unfamiliar non-objects
Number of subjects: 0
Study 10355678 — intervention group
Group type: COMPARATOR
Intervention: Coloured stimuli for identification (natural objects)
Number of subjects: 0
Study 10155618 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0
Study 10155618 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 1683602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 49
Study 1683602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 1683602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol (ISCDC subgroup)
Number of subjects: 49
Study 1683602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol (IDC subgroup)
Number of subjects: 49
Study 6812301 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg diltiazem t.i.d.
Number of subjects: 43
Study 6812301 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg diltiazem t.i.d. (after dose increase)
Number of subjects: 43
Study 6812301 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine t.i.d.
Number of subjects: 43
Study 6812301 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine t.i.d.
Number of subjects: 43
Study 6812301 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term treatment with diltiazem (60 mg or 90 mg t.i.d.)
Number of subjects: 43
Study 6812301 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem vs. Nifedipine
Number of subjects: 43
Study 31290981 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone replacement therapy at doses of 10, 20, or 30 mg/d for 4 weeks per term for three terms
Number of subjects: 70
Study 27435493 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional osseous resective surgery (ORS)
Number of subjects: 13
Study 27435493 — intervention group
Group type: COMPARATOR
Intervention: Fibre retention osseous resective surgery (FibReORS)
Number of subjects: 13
Study 26192235 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation with the TRUCLEAR 8.0 Tissue Removal System
Number of subjects: 84
Study 26192235 — intervention group
Group type: COMPARATOR
Intervention: Bipolar resectoscopy with a rigid 8.5-mm bipolar resectoscope
Number of subjects: 84
Study 25490908 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequately randomized trials
Number of subjects: 0
Study 25490908 — intervention group
Group type: COMPARATOR
Intervention: Inadequately randomized trials
Number of subjects: 0
Study 22658378 — intervention group
Group type: EXPERIMENTAL
Intervention: ixabepilone 40 mg/m² on day 1 plus capecitabine 1000 mg/m² BID on days 1 to 14
Number of subjects: 1973
Study 22658378 — intervention group
Group type: COMPARATOR
Intervention: No/late dose reduction of ixabepilone
Number of subjects: 1973
Study 19303972 — intervention group
Group type: EXPERIMENTAL
Intervention: Equidominant meal (1:1:1)
Number of subjects: 28
Study 19303972 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acid (PUFA)-dominant meal (PUFA-D, 1:1.7:2.3)
Number of subjects: 28
Study 19303972 — intervention group
Group type: COMPARATOR
Intervention: Monounsaturated fatty acid (MUFA)-dominant meal (MUFA-D, 1:1.7:1.2)
Number of subjects: 28
Study 17369599 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-bacterial diet (LBD) with antimicrobial prophylaxis (AP)
Number of subjects: 0
Study 17369599 — intervention group
Group type: COMPARATOR
Intervention: Normal hospital diet (NHD) with antimicrobial prophylaxis (AP)
Number of subjects: 0
Study 17369599 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-bacterial diet (LBD)
Number of subjects: 0
Study 17369599 — intervention group
Group type: COMPARATOR
Intervention: Normal hospital diet (NHD)
Number of subjects: 0
Study 15446406 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 9
Study 15446406 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable membrane (GTR)
Number of subjects: 9
Study 15446406 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EMD and GTR
Number of subjects: 9
Study 11432891 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab (loading dose of 100 to 500 mg/m², followed by weekly infusions of 100 to 250 mg/m² for 7 to 8 weeks) + Radiation Therapy (RT) (70 Gy, 2 Gy/d or hyperfractionated RT 76.8 Gy, 1.2 Gy bid)
Number of subjects: 16
Study 9537429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 50 microg/h
Number of subjects: 8
Study 9537429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 100 microg/h
Number of subjects: 8
Study 9537429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 200 microg/h
Number of subjects: 8
Study 9537429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9537429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide (all doses)
Number of subjects: 8
Study 7702357 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cibenzoline administered as a 2 minute bolus at a dose of 1.2 mg.kg‐1
Number of subjects: 62
Study 7702357 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cibenzoline administered as a 10 minute infusion at a dose of 1.75 mg.kg‐1
Number of subjects: 62
Study 2596434 — intervention group
Group type: EXPERIMENTAL
Intervention: 390 mg ferrous sulfate/d for 2 months
Number of subjects: 412
Study 2596434 — intervention group
Group type: COMPARATOR
Intervention: Hemoglobin
Number of subjects: 412
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimiterol (0.5 mug/kg/min high dose)
Number of subjects: 7
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (0.3 mug/kg/min high dose)
Number of subjects: 7
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline (0.05 mug/kg/min high dose)
Number of subjects: 7
Study 240780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimiterol and Isoprenaline
Number of subjects: 7
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline (compared to rimiterol and salbutamol)
Number of subjects: 7
Study 240780 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal bronchodilator action
Number of subjects: 7
Study 30981696 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib (600 mg twice daily)
Number of subjects: 187
Study 29032007 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 90
Study 29032007 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 90
Study 25040957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue
Number of subjects: 120
Study 25040957 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related fatigue reporting
Number of subjects: 120
Study 25040957 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 120
Study 25040957 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 120
Study 23861324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFM) for 12 weeks
Number of subjects: 40
Study 23861324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 21675275 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxodolol (120 mg)
Number of subjects: 60
Study 21675275 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol (25 mg)
Number of subjects: 60
Study 19330596 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-word test
Number of subjects: 112